{"url":"https://lda.senate.gov/api/v1/filings/1b6e1fde-5f5b-4340-ad7a-e2c267e9ec0e/","filing_uuid":"1b6e1fde-5f5b-4340-ad7a-e2c267e9ec0e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2013,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/1b6e1fde-5f5b-4340-ad7a-e2c267e9ec0e/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"MR. ROBERT CHARLES","dt_posted":"2013-10-09T13:38:53.203000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"322 Massachusetts Avenue, NE","registrant_address_2":"Suite A","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":53458,"url":"https://lda.senate.gov/api/v1/registrants/53458/","house_registrant_id":34953,"name":"THE CHARLES GROUP, LLC","description":"management consulting","address_1":"49 Lucas Lane","address_2":null,"address_3":null,"address_4":null,"city":"Bowdoinham","state":"ME","state_display":"Maine","zip":"04008","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARINA CHARLES","contact_telephone":"+1 301-922-3795","dt_updated":"2026-07-16T12:08:08.292564-04:00"},"client":{"id":158318,"url":"https://lda.senate.gov/api/v1/clients/158318/","client_id":1004443,"name":"WESTPORT PHARMACEUTICALS, LLC","general_description":"product development and manufacturing of pharmaceutical and nutritional products","client_government_entity":false,"client_self_select":false,"state":"MO","state_display":"Missouri","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-15"},"lobbying_activities":[{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"treatment of nonconvertible pharmaceutical products under US counternarcotics laws","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54309,"prefix":"mr","prefix_display":"MR.","first_name":"NELSON","nickname":null,"middle_name":"O","last_name":"BUNN","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}